收藏切换
GPR40 novel agonist SZZ15-11 regulates glucolipid metabolic disorders in spontaneous type 2 diabetic KKAy mice
收藏切换
PDF
Lei LEI1, Jia-yu ZHAI1, Tian ZHOU1, 2, Quan LIU1, Shuai-nan LIU1, Cai-na LI1, *, Hui CAO1, Cun-yu FENG1, Min WU1, Lei-lei CHEN1, Li-ran LEI1, Xuan PAN1, Zhan-zhu LIU1, Yi HUAN1, *, Zhu-fang SHEN1
Acta Pharmaceutica Sinica | 2024, 59(10) : 2782 - 2790
Less
收藏切换
Acta Pharmaceutica Sinica | 2024, 59(10): 2782-2790
GPR40 novel agonist SZZ15-11 regulates glucolipid metabolic disorders in spontaneous type 2 diabetic KKAy mice
Full
Lei LEI1, Jia-yu ZHAI1, Tian ZHOU1, 2, Quan LIU1, Shuai-nan LIU1, Cai-na LI1, *, Hui CAO1, Cun-yu FENG1, Min WU1, Lei-lei CHEN1, Li-ran LEI1, Xuan PAN1, Zhan-zhu LIU1, Yi HUAN1, *, Zhu-fang SHEN1
Affiliations
  • 1. State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Beijing Key Laboratory of Polymorphic Drugs, Diabetes Research Center of Chinese Academy of Medical Sciences, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
  • 2. Department of Pharmacy, the Affiliated Children′s Hospital of Zhengzhou University, Zhengzhou 450018, China
Published: 2024-10-12 doi: 10.16438/j.0513-4870.2024-0410
Outline
收藏切换

G protein-coupled receptor (GPR) 40, as one of GPRs family, plays a potential role in regulating glucose and lipid metabolism. To study the effect of GPR40 novel agonist SZZ15-11 on hyperglycemia and hyperlipidemia and its potential mechanism, spontaneous type 2 diabetic KKAy mice, human hepatocellular carcinoma HepG2 cells and murine mature adipocyte 3T3-L1 cells were used. KKAy mice were divided into four groups, vehicle group, TAK group, SZZ (50 mg·kg-1) group and SZZ (100 mg·kg-1) group, with oral gavage of 0.5% sodium carboxymethylcellulose (CMC), 50 mg·kg-1 TAK875, 50 and 100 mg·kg-1 SZZ15-11 respectively for 45 days. Fasting blood glucose, blood triglyceride (TG) and total cholesterol (TC), non-fasting blood glucose were tested. Oral glucose tolerance test and insulin tolerance test were executed. Blood insulin and glucagon were measured via enzyme-linked immunosorbent assay (ELISA). After mice′s execution, liver tissue was harvested to test TG and TC content. Then pathological morphology of liver was observed through hematoxylin-eosin (HE) staining, and the lipid metabolism relative signal pathway was analyzed by Western blot and RT-PCR. The experiments were approved by the Institutional Animal Care and Use Committee of the Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College. At the same time, Akt phosphorylation level in HepG2 cells and adiponectin in 3T3-L1 cells treated with TNFα were measured with Western blot. The results show that SZZ15-11 not only decreased blood glucose and lipid, improved insulin sensitivity, but also increased fasting blood glucagon and promoted insulin secretion after glucose loading in KKAy mice. Additionally, SZZ15-11 alleviated hepatic steatosis and liver dysfunction in KKAy mice. In liver tissue, SZZ15-11 increased AMPKα phosphorylation level and cholesterol metabolism relative gene Abcg8 transcription. In HepG2 cells, SZZ15-11 increased Akt phosphorylation level. In adipocyte 3T3-L1, SZZ15-11 recovered the decreased adiponectin expression by TNFα. This study proved that GPR40 agonist SZZ15-11 could be a candidate compound for regulating glucolipid metabolic disorder.

G protein-coupled receptor 40  /  type 2 diabetes  /  glucose and lipid metabolism  /  hepatic steatosis  /  insulin resistance
Lei LEI, Jia-yu ZHAI, Tian ZHOU, Quan LIU, Shuai-nan LIU, Cai-na LI, Hui CAO, Cun-yu FENG, Min WU, Lei-lei CHEN, Li-ran LEI, Xuan PAN, Zhan-zhu LIU, Yi HUAN, Zhu-fang SHEN. GPR40 novel agonist SZZ15-11 regulates glucolipid metabolic disorders in spontaneous type 2 diabetic KKAy mice[J]. Acta Pharmaceutica Sinica, 2024 , 59 (10) : 2782 -2790 . DOI: 10.16438/j.0513-4870.2024-0410
Year 2024 volume 59 Issue 10
PDF
222
86
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2024-0410
  • Receive Date:2024-04-28
  • Online Date:2025-11-24
  • Published:2024-10-12
Article Data
Affiliations
History
  • Received:2024-04-28
  • Revised:2024-07-29
Funding
Affiliations
    1. State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Beijing Key Laboratory of Polymorphic Drugs, Diabetes Research Center of Chinese Academy of Medical Sciences, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
    2. Department of Pharmacy, the Affiliated Children′s Hospital of Zhengzhou University, Zhengzhou 450018, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2024-0410
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT